4.6 Review

Resolvins and protectins in the termination program of acute inflammation

Journal

TRENDS IN IMMUNOLOGY
Volume 28, Issue 4, Pages 176-183

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.it.2007.02.007

Keywords

-

Categories

Funding

  1. NIDCR NIH HHS [P50 DE 016191] Funding Source: Medline
  2. NIDDK NIH HHS [DK 074448] Funding Source: Medline
  3. NIGMS NIH HHS [GM 38675] Funding Source: Medline
  4. NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074448] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The physiological resolution of a well-orchestrated inflammatory response is essential to maintain homeostasis. Therefore, gaining a comprehensive understanding in molecular terms of the events that direct the termination of acute inflammation is imperative. Recently, new families of local-acting mediators were discovered that are biosynthesized from the essential fatty acids eicosapentaenoic acid and docosahexaenoic acid. These new chemical mediators are endogenously generated in inflammatory exudates collected during the resolution phase, and were termed resolvins and protectins because specific members of these families control the magnitude and duration of inflammation in animals. In addition, recent results indicate novel actions of resolvins and protectins in removing chemokines ferried from the tissue by apoptotic neutrophils and T cells during resolution. Here, we review recent advances on the biosynthesis and actions of these novel anti-inflammatory and proresolving mediators.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available